BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 29
• 30

• Drug Development

  Vion Pharmaceuticals to Present Survival Data on Laromustine at American Society of Hematology Annual Meeting

  December 4, 2008

   · 

  3 min read
• Drug Development

  Genta Incorporated Release: Tesetaxel, a Leading Oral Taxane in Clinical Development, Receives FDA Designation as an Orphan Drug for Treatment of Patients with Advanced Melanoma

  December 4, 2008

   · 

  1 min read
• BioMidwest

  Vertellus Specialties UK Ltd. Announces Price Change

  December 4, 2008

   · 

  1 min read
• Biotech Beach

  Inovio Biomedical Corporation and VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) to Highlight Recent Advances in Electroporation-Delivered DVA Vaccines at International DNA Vaccines Conference

  December 4, 2008

   · 

  1 min read
• BioCapital

  Sucampo Pharmaceuticals, Inc. Selected as a Finalist for Scrip Awards 2008 Pharma Company of the Year – Small and Medium-Sized Enterprises Award

  December 4, 2008

   · 

  1 min read
• BioMidwest

  Medicsight Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis

  December 4, 2008

   · 

  8 min read
• Job Trends

  GlaxoSmithKline Cuts Further 200 UK Manufacturing Jobs

  December 4, 2008

   · 

  1 min read
• Drug Development

  MannKind Corporation’s Two Phase 3 Studies Meet Goal

  December 4, 2008

   · 

  4 min read
• FDA

  European Commission Approval of New Indication for Roche’s (JOBS) Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure

  December 4, 2008

   · 

  6 min read
• BioCapital

  U.S. FDA Advisers Back Novartis AG Malaria Drug

  December 4, 2008

   · 

  1 min read